肺ステント市場：製品別、エンドユーザー別-2025-2030年の世界予測

肺ステント市場は、2023年に1億1,491万米ドルと評価され、2024年には1億2,409万米ドルに達すると予測され、CAGR 8.08%で成長し、2030年には1億9,802万米ドルに達すると予測されています。

肺ステントは、肺がん、喘息、慢性閉塞性肺疾患（COPD）などの閉塞性気道疾患患者の気道開存性を維持するために使用される医療機器です。気道を悪くした患者の症状を緩和し、気流を改善し、生活の質を向上させる効果的な手段を提供するため、呼吸器内科の分野では必要不可欠なものです。肺ステントは、病院、外来手術センター、専門クリニックで利用されており、適用範囲は気道閉塞を引き起こす悪性疾患と良性疾患の両方に及びます。肺ステント市場は主に、呼吸器疾患の有病率の上昇、ステント技術の進歩、高齢化社会における需要の増加といった要因によって牽引されています。低侵襲手術のニーズが旺盛で、肺ステントの採用をさらに後押ししています。しかし、市場は高コスト、合併症のリスク、規制上のハードルといった課題に直面しており、これが成長を阻害する可能性があります。肺ステント市場の将来的な機会としては、生分解性ステントの進歩、個別化されたステント設計、ステントの柔軟性と生体適合性を高める材料科学によるイノベーションなどが挙げられます。企業は、新製品開発のための研究開発を加速させるために、ヘルスケア機関との相乗効果のある提携や共同研究に注力すべきです。アジア太平洋やラテンアメリカのような医療インフラが発展している地域は、医療費の増加や高度な治療オプションに対する医療従事者の意識の高まりにより、大きな可能性を秘めています。しかし、厳しい規制環境や地域間の購買力のばらつきといった制約は、依然として根強い障害となっています。肺ステント市場の競争は激しく、技術革新とブランド差別化が重視されています。優位に立つためには、企業は継続的な研究開発、特に次世代製品を生み出すためのナノテクノロジーと組織工学への投資を行うべきです。新技術に関する医療従事者のトレーニングに重点を置くことで、市場浸透を促進し、市場競争の中で確固たる足場を築くことができます。

市場力学：急速に進化する肺ステント市場の主要市場インサイトを公開

肺ステント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 肺がんおよびCOPD患者の増加
  • 低侵襲手術に対する需要の増加
  • 世界の老人人口の増加
• 市場抑制要因
  • ステント挿入に伴う合併症
• 市場機会
  • 生分解性ステントが魅力的な選択肢として台頭
  • 非公開会社による研究開発投資の増加
• 市場の課題
  • 代替治療の利用可能性

ポーターの5つの力：肺ステント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：肺ステント市場における外部からの影響の把握

外部マクロ環境要因は、肺ステント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析肺ステント市場における競合情勢の把握

肺ステント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス肺ステント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、肺ステント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨肺ステント市場における成功への道筋を描く

肺ステント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肺がんとCOPDの症例増加
    • 低侵襲手術の需要増加
    • 世界中で増加する高齢者人口
  • 抑制要因
    • ステント挿入に伴う合併症
  • 機会
    • 生分解性ステントが魅力的な選択肢として浮上
    • 非公開会社による研究開発投資の増加
  • 課題
    • 代替治療法の利用可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 肺ステント市場：製品別

• バルーン拡張可能
• 拡張不可
• 自己拡張可能

第7章 肺ステント市場：エンドユーザー別

• 外来手術センター
• 病院

第8章 南北アメリカの肺ステント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の肺ステント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの肺ステント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Abbott Laboratories
• Andramed GmbH
• Asahi Glass Co. Ltd.
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cook Group
• Johnson & Johnson Services, Inc.
• KYOTO MEDICAL PLANNING Co., Ltd.
• Medtronic PLC
• Merit Medical Systems, Inc.
• Micro-Tech（Nanjing）Co., Ltd.
• MicroPort Scientific Corporation
• Taewoong Medical Co., Ltd.
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. LUNG STENTS MARKET RESEARCH PROCESS
• FIGURE 2. LUNG STENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LUNG STENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LUNG STENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LUNG STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LUNG STENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LUNG STENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS LUNG STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS LUNG STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES LUNG STENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES LUNG STENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. LUNG STENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. LUNG STENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LUNG STENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LUNG STENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LUNG STENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LUNG STENTS MARKET DYNAMICS
• TABLE 7. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LUNG STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LUNG STENTS MARKET SIZE, BY NON-EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LUNG STENTS MARKET SIZE, BY SELF-EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. CANADA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES LUNG STENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CHINA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDIA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ITALY LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. POLAND LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. QATAR LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM LUNG STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM LUNG STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. LUNG STENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. LUNG STENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Lung Stents Market was valued at USD 114.91 million in 2023, expected to reach USD 124.09 million in 2024, and is projected to grow at a CAGR of 8.08%, to USD 198.02 million by 2030.

Lung stents are medical devices used to maintain airway patency in patients with obstructive airway diseases such as lung cancer, asthma, and chronic obstructive pulmonary disease (COPD). They are essential in the field of pulmonology because they provide an effective means to alleviate symptoms, improve airflow, and enhance the quality of life for patients with compromised airways. Lung stents are utilized in hospitals, ambulatory surgical centers, and specialized clinics, with application scope covering both malignant and benign conditions that cause airway obstruction. The market for lung stents is primarily driven by factors such as the rising prevalence of respiratory diseases, advancements in stent technologies, and increasing demand among the aging population. There is a robust need for minimally invasive procedures, which further boosts the adoption of lung stents. However, the market faces challenges such as high costs, risk of complications, and regulatory hurdles, which can impede growth. Future opportunities in the lung stent market include advancements in biodegradable stents, personalized stent designs, and innovations driven by material science to enhance stent flexibility and biocompatibility. Companies should focus on synergistic partnerships and collaborations with healthcare institutions to accelerate R&D for new product developments. Regions with developing healthcare infrastructure, like Asia-Pacific and Latin America, highlight significant potential due to rising healthcare expenditure and increasing awareness among healthcare professionals about advanced therapeutic options. However, limitations such as stringent regulatory environments and variability in purchasing power across regions remain persistent obstacles. The nature of the lung stent market is highly competitive, with a focus on technological innovation and brand differentiation. To stay ahead, businesses should invest in ongoing research and development, particularly in nanotechnology and tissue engineering to create next-generation products. Emphasis on training healthcare providers about new technologies can catalyze market penetration and establish a strong foothold amidst market competition.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lung Stents Market

The Lung Stents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising cases of lung cancer and COPD
  • Increasing demand for minimally invasive surgeries
  • Growing geriatric population worldwide
• Market Restraints
  • Complications associated with stent insertion
• Market Opportunities
  • Biodegradable stents emerging as attractive option
  • Increasing R&D investment by private companies
• Market Challenges
  • Availability of alternative treatments

Porter's Five Forces: A Strategic Tool for Navigating the Lung Stents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lung Stents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lung Stents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lung Stents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lung Stents Market

A detailed market share analysis in the Lung Stents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lung Stents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lung Stents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lung Stents Market

A strategic analysis of the Lung Stents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lung Stents Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Andramed GmbH, Asahi Glass Co. Ltd., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Group, Johnson & Johnson Services, Inc., KYOTO MEDICAL PLANNING Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Micro-Tech (Nanjing) Co., Ltd., MicroPort Scientific Corporation, Taewoong Medical Co., Ltd., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Lung Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Balloon-Expandable, Non-Expandable, and Self-Expandable.
• Based on End User, market is studied across Ambulatory Surgery Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of lung cancer and COPD
    • 5.1.1.2. Increasing demand for minimally invasive surgeries
    • 5.1.1.3. Growing geriatric population worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Complications associated with stent insertion
  • 5.1.3. Opportunities
    • 5.1.3.1. Biodegradable stents emerging as attractive option
    • 5.1.3.2. Increasing R&D investment by private companies
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative treatments
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Lung Stents Market, by Product

• 6.1. Introduction
• 6.2. Balloon-Expandable
• 6.3. Non-Expandable
• 6.4. Self-Expandable

7. Lung Stents Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgery Centers
• 7.3. Hospitals

8. Americas Lung Stents Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Lung Stents Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Lung Stents Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Andramed GmbH
• 4. Asahi Glass Co. Ltd.
• 5. Becton, Dickinson and Company
• 6. Boston Scientific Corporation
• 7. Cook Group
• 8. Johnson & Johnson Services, Inc.
• 9. KYOTO MEDICAL PLANNING Co., Ltd.
• 10. Medtronic PLC
• 11. Merit Medical Systems, Inc.
• 12. Micro-Tech (Nanjing) Co., Ltd.
• 13. MicroPort Scientific Corporation
• 14. Taewoong Medical Co., Ltd.
• 15. Terumo Corporation